VIRGINIA RETIREMENT SYSTEMS ET Al Lowers Holdings in Procter & Gamble Company (The) $PG

VIRGINIA RETIREMENT SYSTEMS ET Al trimmed its position in Procter & Gamble Company (The) (NYSE:PG) by 5.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 175,200 shares of the company’s stock after selling 10,800 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Procter & Gamble were worth $25,108,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently bought and sold shares of PG. Maseco LLP acquired a new stake in Procter & Gamble in the fourth quarter valued at $28,000. Saranac Partners Ltd acquired a new stake in Procter & Gamble in the third quarter valued at $30,000. Caitlin John LLC acquired a new stake in Procter & Gamble in the third quarter valued at $34,000. Anfield Capital Management LLC lifted its holdings in Procter & Gamble by 121.5% in the fourth quarter. Anfield Capital Management LLC now owns 237 shares of the company’s stock valued at $34,000 after acquiring an additional 130 shares during the period. Finally, Legacy Wealth Managment LLC ID lifted its holdings in Procter & Gamble by 162.6% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 239 shares of the company’s stock valued at $34,000 after acquiring an additional 148 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $142.34 on Thursday. The company’s 50-day moving average price is $146.77 and its 200 day moving average price is $148.33. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.99. The stock has a market cap of $331.46 billion, a price-to-earnings ratio of 20.81, a PEG ratio of 6.17 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.44.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same quarter in the previous year, the company posted $1.54 EPS. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 24th will be paid a $1.0885 dividend. This represents a $4.35 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend is Friday, April 24th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $1.06. Procter & Gamble’s dividend payout ratio is presently 63.60%.

Analyst Ratings Changes

PG has been the subject of a number of recent analyst reports. Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Piper Sandler boosted their price objective on shares of Procter & Gamble from $142.00 to $145.00 and gave the stock a “neutral” rating in a research report on Friday, April 24th. Weiss Ratings reissued a “hold (c)” rating on shares of Procter & Gamble in a research note on Friday, March 27th. Rothschild & Co Redburn lowered their price objective on shares of Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating on the stock in a research note on Monday, April 27th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating on the stock in a research note on Friday, April 17th. Eleven equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $161.06.

Insider Activity at Procter & Gamble

In related news, insider Moses Victor Javier Aguilar sold 15,169 shares of the business’s stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the completion of the transaction, the insider owned 44,735 shares of the company’s stock, valued at approximately $7,259,595.80. The trade was a 25.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Susan Street Whaley sold 1,809 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $159.46, for a total transaction of $288,463.14. Following the completion of the transaction, the insider directly owned 30,215 shares of the company’s stock, valued at $4,818,083.90. The trade was a 5.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 22,527 shares of company stock valued at $3,667,283. 0.20% of the stock is owned by insiders.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.